Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII

Thrombosis Research

Volumn 84, Issue 1, 1996, Pages 55-66

  Fischer, Bernhard E ^a   Kramer, Geert ^a   Mitterer, Artur ^a   Grillberger, Leopod ^a   Reiter, Manfred ^a   Mundt, Wolfgang ^a   Dorner, Friedrich ^a   Eibl, Johann ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

collagen binding; factor VIII; heparin; multimerization; recombinant von Willebrand factor; ristocetin cofactor activity

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT VON WILLEBRAND FACTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0030271856     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00161-2     Document Type: Article

References (52)

1. 1. RUGGERI, Z.M. and WARE, J. The structure and function of von Willebrand factor. Thromb Haemost 67, 594-599, 1992.
2. 2. RUGGERI, Z.M. and ZIMMERMANN, T.S. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57, 1140-1143, 1981.
3. 3. RUGGERI, Z.M. and WARE, J. Von Willebrand factor. FASEB J 7, 308-316, 1993.
4. 4. MANNUCCI, P.M., ABILDGAARD, C.F., GRALNICK, H.R., HILL, F.G.H., HOYER, L.W., LOMBARDI, R., NILSSON, I.M., TUDDENHAM, E. and MEYER, D. Multicenter comparison of von Willebrand factor multimer sizing techniques. Thromb Haemost 54, 873-877, 1985.
5. 5. LYNCH, D.C. The fine structure of von Willebrand factor multimers and type IIa von Willebrands disease. Ann NY Acad Sci 138, 138-152, 1993.
6. 6. PANNEKOEK, H. and VOOREBERG, J. Molecular cloning, expression and assembly of multimeric von Willebrand factor. Bailliere's Clin Haematol 2, 879-896, 1989.
7. 7. SCOTT, J.P. and MONTGOMERY, R.R. Therapy of von Willebrand disease. Sem Thromb Hemost 19, 37-47, 1993.
8. 8. MANNUCCI, P.M., LATTUADA, A. and RUGGERI, Z.M. Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood 83, 3018-3027, 1994.
9. 9. RUGGERI, Z.M. and ZIMMERMAN, T.S. Variant von Willebrand disease. J Clin Invest 65, 1318-1325, 1980.
10. 10. SIXMA, J.J., SAKARIASSEN, K.S., BEESER-VISSER, N.H., OTTENHOF-ROVERS, M. and BOLHUIS, P.A. Adhesion of platelets to human artery subendothelium: Effect of factor VIII-von Willebrand factor of various multimeric composition. Blood 63, 128-139, 1984.
11. 11. RUGGERI, Z.M. and ZIMMERMAN, T.Z. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57, 1140-1143, 1981.
12. 12. RUGGERI, Z.M. and ZIMMERMAN, T.S. Classification of variant von Willebrand's disease subtypes by analysis of functional characteristics and multimeric composition of factor VIII/von Willebrand factor. Ann New York Acad Sci 370, 205-209, 1981.
13. 13. SIXMA, J.J., SCHIPHORST, M.E., VERWEIJ, C.L. and PANNEKOEK, H. Effects of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem 196, 369-375, 1991.
14. 14. FUJIMURA, Y., TITANI, K., HOLLAND, L.Z., RUSSELS, S.R., ROBERTS, J.R., EIDER, J.H., RUGGERI, Z.M. and ZIMMERMAN, T.S. Von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem 261, 381-385, 1986.
15. 15. MOHRI, H., YOSHIOKA, A., ZIMMERMAN, T.S. and RUGGERI, Z. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. J Biol Chem 264, 17361-17367, 1989.
16. 16. PIETU, G., MEULIEN, P., CHEREL, G., DIAZ, J., BARUCH, D., COURTNEY, M. and MEYER, D. Production in Escherichia coli of a biologically active subfragment of von Willebrand factor corresponding to the platelet glycoprotein Ib, collagen and heparin binding domains. Biochem Biophys Res Com 164, 1339-1347, 1989.
17. 17. CRUZ, M.A., HANDIN, R.I. and WISE, R.J. The interaction of the von Willebrand factor A1 domain with platelet glycoprotein Ib/IX. J Biol Chem 268, 21238-21245, 1993.
18. 18. AZUMA, H., SUGIMOTO, M., RUGGERI, Z.M. and WARE, J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemost 69, 192-196, 1993.
19. 19. SUGIMOTO, M., DENT, J., MCCLINTON, R., WARE, J. and RUGGERI, Z.M. Analysis of structure-function relationships in the platelet membran glycoprotein Ib-binding domain of von Willebrand's factor by expressing of deletion mutants. J Biol Chem 268, 12185-12192, 1993.
20. 20. FISCHER, B., MITTERER, A., SCHLOKAT, U., DENBOUWMEESTER, R. and DORNER, F. Structural analysis of recombinant von Willebrand factor: identification of heteroand homo-dimers. FEBS Let. 351, 345-348, 1994.
21. 21. FISCHER, B.E., SCHLOKAT, U., MITTERER, A., REITER, M., MUNDT, W., TURECEK, P.L., SCHWARZ, H.P. and DORNER, F. Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin. FEBS Lett 375, 259-262, 1995.
22. 22. SIEKMANN, J., TURECEK, P.L., FISCHER, B.E., MITTERER, A., SCHLOKAT, U., FALKNER, F., DORNER, F. and SCHWARZ, H.P. Characterization of plasma-derived and recombinant human vWF by improved collagen binding assays. Thromb Haemost 73, 1160, 1995.
23. 23. O'SHANNESSY, D.J., BRINGHAM-BURKE, M., SONESON, K.K., HENSLEY, P. and BROOKS, I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem 212, 457-468, 1993.
24. 24. KARLSSON, R. Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. Anal Biochem 221, 142-151, 1994.
25. 25. MALMQVIST, M. Biospecific interaction analysis using biosensor technology. Nature 361, 186-187, 1993.
26. 26. SOBEL, M., SOLER, D.F., KERMODE, J.C. and HARRIS, R.B. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 267, 8857-8862, 1992.
27. 27. DE ROMEUF, C. and MAZURIER, C. Heparin binding assay of von Willebrand factor (vWF) in plasma milieu - Evidence of the importance of the multimerization degree of vWF. Thromb Haemost 69, 436-440, 1993.
28. 28. FRESSINAUD, E. and MEYER, D. Von Willebrand factor and platelet interactions with the vessel wall. Blood Coagul Fibrinolysis 2, 333-340, 1991.
29. 29. KALIFATIS, M., TAKAHASHI, Y., GIRMA, J.-P. and MEYER, D. Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residue Gly 911 and Glu 1, 365. Blood 70, 1577-1583, 1987.
30. 30. PARETI, F.I., NIIYA, K., MCPERSON, J.M. and RUGGERI, Z.M. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 262, 13835-13841, 1987.
31. 31. PROIR, C.P., CHU, V., CAMBOU, B., DENT, J.A., EBERT, B., GORE, R., HOLT, J., ISISH, J., MITSCHELEN, J., MCCLINTOCK, R.A., SEARFOSS, G., RICCA, G.A., TARR, C., WEBER, D., WARE, J.L. RUGGERI, Z.M., and HRINDA, M. Optimization of a recombinant von Willebrand factor fragment as an antagonist of the platelet glycoprotein Ib receptor. Bio/Technol 11, 709-713, 1993.
32. 32. CRUZ, M. A., YUAN, H., LEE, J.R., WISE, R.J. and HANDIN, R.I. Interaction of the von Willebrand factor (vWF) with collagen. J Biol Chem 270, 10822-10827, 1995.
33. 33. RIBBA ,A.S., VOORBERG, J., MEYER, D., PANNEKOEK, H. and PIETO, G. Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease. J Biol Chem 267, 23209-2315, 1992.
34. 34. WISE, R.J., PITTMAN, D.D., HANDIN, R.I., KAUFMAN, R.J. and ORKIN, S.H. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52, 229-236, 1988.
35. 35. VERWEIJ, C.L., HART, M. and PANNEKOEK, H. Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWf multimer formation. EMBO J 6, 2885-2890, 1987.
36. 36. MEULIEN, P., NISHINO, M., MAZURIER, C., DOTT, K., PIETU, G., JORIEU S., PAVIRANI, A., GIRMA, J.P., OUFKIR, D., COURTNEY, M. and MEYER, D. Processing and characterization of recombinant von Willebrand factor expressed in different cell types using a vaccinia virus vector. Thromb Haemost 67, 154-160, 1992.
37. 37. MAYADAS, T.N. and WAGNER, D.D. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proc Natl Acad Sci USA 89, 3531-3535, 1992.
38. 38. KAUFMAN, R.J., WASLEY, L.C., DAVIES, M.V., WISE, R.J., ISRAEL, D.I. and DORNER, A.J. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in chinese hamster ovary cells. Mol Cell Biol 9, 1233-1242, 1989.
39. 39. VOORBERG, J., FRONTIJN, R., CALAFAT, J., JANSSEN, H., VAN MOURIK, J.A. and PANNEKOEK, H. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J 12, 749-758, 1993.
40. 40. RANDI, A.M., JORIEUX, S., TULEY, E.A., MAZURIER, C. and SADLER, J.E. Recombinant von Willebrand factor Arg578 -> Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin. J Biol Chem 267, 21187-21192, 1992.
41. 41. WISE, R.J., DORNER, A.J., KRANE, M., PITTMAN, D.D. and KAUFMAN, R. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 266, 21948-21955, 1991.
42. 42. MATSUSHITA, T. and SADLER, J.E. Identification of amino acids residues essential for von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 270, 13406-13414, 1995.
43. 43. LANKHOF, H., WU, Y.P., VINK, T., SCHIPHORST, M.E., ZERWES, H.G., DE GROOT, G. and SIXMA, J.J. Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. Blood 86, 1035-1042, 1995.
44. 44. CAREW, J.A., QUINN, S.M., START, J.H. and LYNCH, D.C. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein Ib. J Clin Invest 90, 2258-2267, 1992.
45. 45. BONTHRON, D.T., HANDIN, R.I., KAUFMAN, R.J., WASLEY, L.C., ORR, E.C., MITSOCK, L.M., EWENSTEIN, B., LOSCALZO, J., GINSBURG, D. and ORKIN, S.H. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature 324, 270-273, 1986.
46. 46. RABINOWITZ, I., RANDI, A.M., SHINDLER, K.S., TULEY, E.A., RUSTAGI, P.K. and SADLER, J.E. Type IIB mutation His-505-Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 268, 20497-20501, 1993.
47. 47. GANZ, P.R., ATKINS, J.S., PALMER, D.S., DUDANI, A.K., HASHEMI, S. and LUISON, F. Definition of the affinity of binding between human von Willebrand factor and coagulation factor VIII. Biochem Biophys Res Comun 180, 231-237, 1991.
48. 48. LAYET, S., GIRMA, J.P., OBERT, B., PEYNAUD-DEBAYLE, E., BIHOREAU, N. and MEYER, D. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely. Biochem J 282, 129-137, 1992.
49. 49. NISHINO, M., MIURA, S., YOSHIOKA, S., KUWAHARA, I., NISHIMURA, T., HAMADA, K., and FUKUI, H. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan. Intern J Hematol 57, 163-173, 1993.
50. 50. LEYTE, A., VERBEET, M.Ph., BRODNIEWICZ-PROBA, T., VAN MOURIK, J. and MERTENS, K. Biochem J 257, 679-683, 1989.
51. 51. ZUCKER, M.B., SOBERANO, ME., JOHNSON, A.J., FULTON, A.J., KOKALSKI, S. and ADLER, M. The in vitro association of antihemophilic factor and von Willebrand factor. Thromb Haemost 49, 37-42, 1983.
52. 52. VLOT, A.J., KOPPELMAN, S.J., VAN DEN BERG, M.H., BOUMA, B.N. and SIXMA, J.J. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 85, 3150-3157, 1995.